UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2022
Commission File Number: 001-40277
OLINK HOLDING AB (PUBL)
(Exact Name of Registrant as Specified in its Charter)
Uppsala Science Park
SE-751 83
Uppsala, Sweden
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
As previously announced, on January 12, 2022, Jon Heimer, CEO of Olink Holding AB (publ) (the "Company"), made a presentation virtually at 9:00 am ET at the 40th Annual J.P. Morgan Healthcare Conference. An archived webcast of the event will be available on the "Events" section of the Company’s website at https://investors.olink.com/news-events/events. A copy of the presentation is furnished as Exhibit 99.1 to this Form 6-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| OLINK HOLDING AB (PUBL) |
| |
| |
| By: | /s/ Jon Heimer |
| Name: | Jon Heimer |
| Title: | Chief Executive Officer |
Date: January 12, 2022